Patent ductus arteriosus complicating respiratory distress syndrome

Area of Science:

• Neonatal Medicine
• Pediatric Cardiology
• Cardiovascular Surgery

Background:

• Patent ductus arteriosus (PDA) is a common complication in premature infants with respiratory distress syndrome (RDS).
• Untreated PDA can lead to significant morbidity, including pulmonary overcirculation and congestive heart failure (CHF).

Purpose of the Study:

• To investigate the incidence of PDA-associated CHF in infants with RDS.
• To evaluate the outcomes of medical and surgical management for PDA-induced CHF.

Main Methods:

• Retrospective analysis of 396 patients diagnosed with RDS.
• Identification of patients with PDA and subsequent development of CHF.
• Review of medical and surgical treatment strategies and their efficacy.

Main Results:

• PDA was diagnosed in 76 (19%) of infants with RDS.
• Fifteen patients (20% of those with PDA) developed evidence of excessive pulmonary blood flow and CHF.
• CHF was not recognized before 10 days of age in any patient.
• Medical management improved seven of the 15 patients.
• Surgical intervention for five patients who failed medical management resulted in survival, but only two experienced improvement.

Conclusions:

• PDA is a significant concern in RDS, with a notable subset developing CHF.
• Delayed recognition of CHF complicates management.
• While medical management can be effective, surgical outcomes for refractory CHF are suboptimal, highlighting the need for optimized treatment strategies.